Griseofulvin
- Product NDC
- 64980-186
- 11-digit product format
- 649800186
- Labeler code
- 64980
- Product ID
- 64980-186_7a7e6024-fcb1-4e9a-8de4-30d7c97210c0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Griseofulvin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals Inc.
- Application
- ANDA202482
- Marketing category
- ANDA
- Marketing start
- 2012-12-06
- Marketing end
- 0000-00-00
- Substance
- GRISEOFULVIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-186-01 | 64980018601 | 100 TABLET in 1 BOTTLE (64980-186-01) | 100 tablet | 2012-12-06 | 0000-00-00 | No | No | Current |
| 64980-186-03 | 64980018603 | 30 TABLET in 1 BOTTLE (64980-186-03) | 30 tablet | 2016-07-01 | 0000-00-00 | No | No | Current |